Responses
Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
219 Prevalence of genomic alterations in XernaTM tumor microenvironment subtypes in colorectal cancer patients
Compose a Response to This Article
Other responses
No responses have been published for this article.